ClinicalTrials.gg
Drug

Lansoprazole clinical trials

Also written Prevacid, Takepron and AG-1749.

studies test it
90
open now
5
in phase 3
19
first study started
2002

How each study uses Lansoprazole is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Lansoprazole studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
10 May 1995 · PREVACID · NDA 020406 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Lansoprazole
52
Lansoprazole 15 mg
2
Lansoprazole Capsules
2
lanston LFDT
2
Lansoprazole 30mg
2

Brand

Prevacid
18
Takepron
7
Zoton
1
Agopton
1

Development codes

AG-1749
5

Other names

Lanzoprazole
1

In one entry with another drug

Given together, or one or the other

Lansoprazole/Domperidone
2
Duolans
2

Studies by the year they started

89 studies that test it; most in 2006 (12)

Studies that test Lansoprazole, by start year
YearStudies
20021
20035
20043
20057
200612
20076
20085
20095
20107
20111
20124
20134
20144
20151
20161
20175
20186
20191
20203
20213
20221
20233
20241

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
18
Phase 2
12
Phase 3
19
Phase 4
33
No phase
9

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 33 · Other 57

Takeda (12) · Novartis (4) · National Taiwan University Hospital (4) · Teva Pharmaceuticals USA (3) · AstraZeneca (3) · First Affiliated Hospital of Zhejiang University (2) · Mackay Memorial Hospital (2) · Neutec Ar-Ge San ve Tic A.Ş (2)

Often tested with

Tested in the same studies.

Amoxicillin (9) · Clarithromycin (7) · Esomeprazole (6) · Metronidazole (4) · Pantoprazole (3) · Omeprazole (3) · Vonoprazan (3) · Aspirin (2)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 3 phase 3 studies under way

Lansoprazole is the comparator. A study of two new drugs counts under both.

  • 1Ilaprazole · Il-Yang Pharm. Co., Ltd. · next primary completion Aug 2027
  • 1Zastaprazan · Onconic Therapeutics Inc. · next primary completion Oct 2028
  • 1Fexuprazan · Daewoong Pharmaceutical Co. LTD. · next primary completion Apr 2028
Reaching primary completion within a year · 2, 1 in phase 3

Studies that test Lansoprazole, phase 3 first.

Studies

Open first, then newest update. How each study uses Lansoprazole is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 90

See all 90 studies that test Lansoprazole →

Given beside what is tested · 22 — Lansoprazole is usual care or a partner of the new treatment

Showing 20 of 22.

As the comparator · 53 — what is tested is compared with Lansoprazole

Showing 20 of 53.

Codes

What other systems call Lansoprazole · ClinicalTrials.gg INT008976

  • MeSH (NLM) D064747LansoprazoleConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 0K5C5T2QPGLANSOPRAZOLEConfirmed FDA, NLM, Wikidata
  • RxNorm 17128Confirmed FDA, Wikidata
  • Wikidata Q254296lansoprazoleConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C29150LansoprazoleOne source FDA
  • DrugBank DB00448One source Wikidata

Also registered as lansoprazole sodium (UNII GV9NY1U369).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.